Joseph K. Belanoff
2009
In 2009, Joseph K. Belanoff earned a total compensation of $1.3M as Chief Executive Officer at Corcept Therapeutics, a 216% increase compared to previous year.
Compensation breakdown
| Option Awards | $909,350 |
|---|---|
| Salary | $440,272 |
| Total | $1,349,622 |
Belanoff received $909.4K in option awards, accounting for 67% of the total pay in 2009.
Belanoff also received $440.3K in salary.
Rankings
In 2009, Joseph K. Belanoff's compensation ranked 3,505th out of 9,885 executives tracked by ExecPay. In other words, Belanoff earned more than 64.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,505 out of 9,885 | 65th |
Division Manufacturing | 1,224 out of 3,690 | 67th |
Major group Chemicals And Allied Products | 238 out of 866 | 73rd |
Industry group Drugs | 138 out of 638 | 78th |
Industry Pharmaceutical Preparations | 111 out of 446 | 75th |
Source: SEC filing on May 17, 2010.
Belanoff's colleagues
We found three more compensation records of executives who worked with Joseph K. Belanoff at Corcept Therapeutics in 2009.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019